HEALTHCARE COMPANIES NEWS

• "Roche submits application to FDA for trastuzumab-DM1 in previously treated advanced HER2-positive breast cancer" - Roche - www.roche.com

• ASCO Annual Meeting, Chicago, Illinois, June 4-8, 2010 - Roche

• "Inportant progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1" - Roche - www.roche.com

• "Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancer" - Roche - www.roche.com

• "Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer""> - Roche - www.roche.com

Owner and Editor-in-Chief Gianpaolo Andreoletti, Oncologist and Science Journalist P.IVA. 01823870165

PRIVACY AND LEGAL DISCLAIMER